What is the Biocatalysis Market Size?
The global biocatalysis market was valued at USD 642.48 million in 2025 and is projected to reach approximately USD 1,206.02 million by 2035, growing from USD 684.24 million in 2026 at a CAGR of 6.50% during the forecast period from 2026 to 2035. Market growth is driven by the increasing demand for sustainable and environmentally friendly manufacturing processes, expanding applications across various industries, and rising consumer preference for natural, clean-label products.
Get Sample : https://www.precedenceresearch.com/sample/7180
Market Highlights
- North America dominated the market, holding the largest share in 2025.
- The Asia Pacific is expected to grow at the fastest rate from 2026 to 2035.
- By technology, the enzyme-based biocatalysis segment held the biggest market share in 2025.
- By technology, the whole-cell biocatalysis segment is growing at the fastest CAGR from 2026 to 2035.
- By product type, the enzymes segment contributed the highest market share in 2025.
- By product type, the whole-cell catalysts segment is expected to expand at a noteworthy CAGR from 2026 to 2035.
- By application, the pharmaceutical & drug manufacturing segment captured the major market share of the market in 2025.
- By application, the biofuels & renewable energy segment growing at a strong CAGR between 2026 and 2035.
- By end-user, the pharmaceutical & biotech companies segment held the largest share of the market in 2025.
- By formulation, the liquid enzyme preparation segment dominated the market in 2025.
What is the Biocatalysis Market?
The biocatalysis market is witnessing steady growth, driven by the increasing demand for environmentally friendly manufacturing processes, process intensification, and customized enzyme solutions. Biocatalysis involves the use of enzymes and whole-cell biocatalysts to catalyze chemical reactions in a highly selective, efficient, and sustainable manner across industrial, pharmaceutical, and biotechnological applications.
As industries focus on sustainability and operational efficiency, biocatalysis has emerged as a key technology that supports green chemistry principles, reduces energy consumption, enhances product yields, and minimizes environmental impact. Its applications span a wide range of sectors, including pharmaceuticals, fine chemicals, biofuels, food processing, agriculture, and environmental management, making it an essential tool for advancing cleaner and more sustainable production processes worldwide.
How Is Artificial Intelligence Impacting the Biocatalysis Market?
Artificial intelligence (AI) is revolutionizing the biocatalysis market by accelerating enzyme discovery, optimization, and development processes. AI-powered tools are transforming protein engineering from a field largely dependent on naturally occurring enzymes to one capable of designing novel, customized biocatalysts with enhanced performance, stability, and specificity. This technological advancement is significantly reducing development timelines and enabling the faster commercialization of enzyme-based solutions across multiple industries.
The growing integration of AI in biocatalysis is expected to contribute substantially to market expansion over the coming decade. In addition, AI-driven biotechnology companies are attracting considerable investment from both private and public sectors, fueling research initiatives focused on developing next-generation enzymes and innovative biocatalytic applications. As a result, AI is becoming a critical driver of innovation, efficiency, and growth within the global biocatalysis industry.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 642.48 Million |
| Market Size in 2026 | USD 684.24 Million |
| Market Size by 2035 | USD 1,206.02 Million |
| Market Growth Rate from 2026 to 2035 | CAGR of 6.50% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
Value Chain Analysis of the Biocatalysis Market
- Discovering Enzymes and Engineering Strains: The focus of upstream activities is via microbe screening, genetically modifying microbes, and creating proteins, which produce biocatalysts that are highly selective and stable. Having extensive intellectual property and research and development (R&D) capabilities creates a significant competitive advantage at this stage.
Key Players: Novozymes, Codexis, BASF - Producing and Formulating Biocatalysts: This portion of the value chain encompasses all aspects of the fermentation, downstreaming processes, the immobilization of enzymes, as well as the formulation of enzymes to be usable by customers in various industrial environments.
Key Players: DSM-Firmenich, Amano Enzyme, DuPont - Integrating End-Users and Optimizing Manufacturing Processes: End-users are looking for all-in-one solutions, including technical support, help with compliance to regulatory requirements, and the selection of default solutions to improve production efficiency while reducing waste and energy costs.
Key Players: Evonik Industries, AB Enzymes, Chr. Hansen
Recent Developments
- In July 2025, the CATCO2NVERS project, presented at Biotrans, involves a collaboration with Wageningen University to use engineered enzymes to convert carbon dioxide into high-value chiral molecules, such as D-lactic acid.(Source: https://catco2nvers.eu)
- In March 2024, Kerry launched Biobake Fibre in Europe, an enzyme solution for bakery products. While primarily a European launch, such innovations often signal future rollouts or increased availability in the highly connected APAC markets. (Source: https://fooddrinkinnovations.com)
Check this Report too: High Power Graphite Electrode Market
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7180
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 8440